The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

DaVita HealthCare Partners Inc

NYSE: DVA
Last

(U.S.) $62.56

Today's change-0.01 -0.02%
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.
 

DaVita HealthCare Partners Inc

NYSE: DVA
Last

(U.S.) $62.56

Today's change-0.01 -0.02%
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.

DaVita HealthCare Partners Inc down slightly

DaVita HealthCare Partners Inc closed down just (U.S.)$0.01 Friday to (U.S.)$62.56. Over the last five days, shares have lost 2.10% and sit 1.96% above their 52-week low. This security has underperformed the S&P 500 by 7.39% during the last year.

Key company metrics

  • Open(U.S.) $61.62
  • Previous close(U.S.) $62.57
  • High(U.S.) $64.21
  • Low(U.S.) $61.36
  • Bid / Ask(U.S.) $59.27 / (U.S.) $62.50
  • YTD % change-10.26%
  • Volume2,348,909
  • Average volume (10-day)1,429,241
  • Average volume (1-month)1,410,381
  • Average volume (3-month)1,374,473
  • 52-week range(U.S.) $61.36 to (U.S.) $85.17
  • Beta1.07
  • Trailing P/E28.22×
  • P/E 1 year forward15.50×
  • Forward PEG1.22×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.22
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+4.74%

Based on its net profit margin of 4.74%, DaVita HealthCare Partners Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue3,5263,4353,2883,328
Total other revenue--------
Total revenue3,5263,4353,2883,328
Gross profit1,025989925962
Total cost of revenue2,5012,4462,3632,366
Total operating expense3,0162,9543,3522,876
Selling / general / administrative356354344361
Research & development--------
Depreciation / amortization162159154153
Interest expense (income), net operating--------
Unusual expense (income)004950
Other operating expenses, total--------
Operating income509481-64452
Interest income (expense), net non-operating-103-152-97-131
Gain (loss) on sale of assets--------
Other--------
Income before tax408331-162354
Income after tax261208-76250
Income tax, total147123-86104
Net income216170-111208
Total adjustments to net income--------
Net income before extra. items216170-111208
Minority interest-45-37-34-42
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items216170-111208
Inc. avail. to common incl. extra. items216170-111208
Diluted net income216170-111208
Dilution adjustment------0
Diluted weighted average shares217218213218
Diluted EPS excluding extraordinary itemsvalue per share1.000.78-0.520.96
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.000.780.990.96